Skip to content
Search

Latest Stories

Gita Gopinath promoted as IMF’s first deputy managing director

Gita Gopinath promoted as IMF’s first deputy managing director

GITA Gopinath, the International Monetary Fund (IMF)'s Indian-American chief economist has been promoted as its first deputy managing director.

Her elevation is in recognition of her leadership in helping the global economy and the IMF navigate the "twists and turns" of the "worst economic crisis of our lives".


Gopinath would replace Geoffrey Okamoto who plans to leave the organisation early next year, Kristalina Georgieva, its managing director announced on Thursday (2).

Gopinath, who was scheduled to return to her academic position at Harvard University in January 2022, has decided to stay, she said.

Gopinath, 49, has served as the first female chief economist of the Washington-based global lender for three years.

"Both Geoffrey and Gita are tremendous colleagues - I am sad to see Geoffrey go but at the same time, I am delighted that Gita has decided to stay and accept the new responsibility of being our first deputy managing director (FDMD)," said Georgieva.

She said Gopinath's contribution to the Fund's work has already been exceptional, especially her "intellectual leadership in helping the global economy and the Fund to navigate the twists and turns of the worst economic crisis of our lives."

She also said Gopinath has garnered respect and admiration across member countries and the institution with a proven track record in leading analytically rigorous work on a broad range of issues.

"Especially given that the pandemic has led to an increase in the scale and scope of the macroeconomic challenges facing our member countries, I believe that Gita - universally recognised as one of the world's leading macroeconomists - has precisely the expertise that we need for the FDMD role at this point. Indeed, her particular skill set - combined with her years of experience at the Fund as the chief economist - make her uniquely well qualified. She is the right person at the right time," Georgieva said in a statement.

Under Gopinath's leadership, the IMF's research department had gone from “strength to strength,” particularly highlighting its contributions in multilateral surveillance via the World Economic Outlook, a new analytical approach to help countries respond to international capital flows (the integrated policy framework).

"I am honoured and humbled to become the IMF's next FDMD," Gopinath said on her new appointment.

Gopinath noted that over the past three years she had the opportunity to experience first-hand and be a part of the hugely important work done by the IMF at the intersection of rigorous economic analysis and public policy.

"It has been so gratifying to see the positive impact of our work on economies and on the lives of so many people worldwide. As the pandemic continues its grip on us, the work of the Fund has never been more critical and international cooperation never more important," she said and thanked Georgieva and the IMF Board for giving her the opportunity.

Georgieva noted that given the increasingly complex policy choices and difficult trade-offs facing the IMF's 190 member countries - exacerbated by the pandemic - some realignment in the roles and responsibilities of the Fund's senior management team is being undertaken.

In particular, the FDMD will take the lead on surveillance and related policies, oversee research and flagship publications and help foster the highest quality standards for IMF publications, she said.

(PTI)

More For You

Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less

Yvonne Strahovski reveals shocking ending for 'The Handmaid’s Tale' final season, calls it the rebellion

Yvonne Strahovski hints at a thrilling conclusion in The Handmaid’s Tale final season, teasing shocking twists and emotional turns

Getty/Instagram

Yvonne Strahovski reveals shocking ending for 'The Handmaid’s Tale' final season, calls it the rebellion

As The Handmaid’s Tale wraps up its long and intense run, Yvonne Strahovski has given a glimpse into what’s coming next and it sounds like fans should brace themselves. Talking about the sixth and final season, Strahovski hinted at dramatic turns, especially when it comes to Serena Joy Waterford, the controversial character she’s played since the beginning.

In a chat on CBS Mornings Plus, Strahovski didn’t confirm any clear direction for Serena, but she did say that this season might be the character’s biggest reckoning yet. “This is probably Serena’s biggest opportunity to truly face the weight of her actions,” she said. Whether that leads to redemption or a deeper descent remains to be seen, but it’s clear her arc is far from over.

Keep ReadingShow less
Eric Dane

There is currently no cure for ALS

Getty

Grey’s Anatomy and Euphoria star Eric Dane diagnosed with ALS

Eric Dane, best known for his roles in Grey’s Anatomy and Euphoria, has revealed he has been diagnosed with amyotrophic lateral sclerosis (ALS).

ALS, also referred to as motor neurone disease (MND) in the UK, is an incurable condition that progressively damages nerve cells in the brain and spinal cord, leading to increasing muscle paralysis. The disease affects around 153,000 people in the UK, though awareness of its wider range of symptoms remains relatively low.

Keep ReadingShow less
Harmanpreet to lead India in ODI tri-series

Harmanpreet Kaur

Harmanpreet to lead India in ODI tri-series

STAR batter Harmanpreet Kaur returned as India women’s team captain for the ODI tri-series in Sri Lanka starting later this month after she was rested for the home series against Ireland in January.

The BCCI women’s selection committee picked a 15-member squad with Smriti Mandhana as Harmanpreet’s deputy for the April 27 to May 11 tournament, which will also involve South Africa besides hosts Sri Lanka. India will face Sri Lanka in the tournament opener on April 27.

Keep ReadingShow less